07.21.14 -- White House, WHO Commit To Global Action Plan On Antimicrobial Resistance
Best Practices In Standardizing Single-Use Device Connectivity By Eric Langer, President and Managing Partner, BioPlan Associates, Inc.
The spread of single-use devices in the biopharmaceutical manufacturing industry has been well documented, with some devices reaching penetration rates approaching 90 percent, according to various studies conducted by BioPlan Associates. Yet there remains plenty of room for further adoption of single-use, disposable devices, particularly in commercial-scale production, where they have yet to displace traditional stainless-steel systems.
Article: Improvements In Single-Use Bioprocess Product Testing By Gregg A Larson, Single-Use, Parker domnick hunter Process Filtration
Testing of single-use bioprocessing products is performed to mitigate risk for customers by validating that products will perform as intended and reducing the possibility they will damage or contaminate the biological materials processed through them.
Q&A: How To Protect High-Value Media With Single-Use Connectors By Trisha Gladd, Editor, Bioresearch Online and Pharmaceutical Online
When dealing with high-value products in your downstream processes, the last thing you want is for your media to end up on the plant floor. Making sure your systems are securely connected is a vital part of preventing those failures from happening. I recently sat down with John Boehm, business unit manager, bioprocessing, at Colder Products Company, to discuss the evolution of single-use connection technology, and to get his take on how connectors have had to adapt to the life sciences industry.
White Paper: Advances In Downstream Single-Use Technologies Enable Greater Process Control And Higher Protein Titers By Derek Masser, ASI Life Sciences
Downstream protein purification (the stage in which a protein is isolated and purified) is one of the last steps in biotherapeutic manufacturing. Single-use technologies are an increasingly popular choice for both upstream and downstream bioprocessing because they offer significant benefits over traditional multiuse manufacturing systems. Single-use technologies also provide an array of logistical benefits, including reduced costs, minimized risk of cross-contamination, and improved operational efficiency.
White Paper: Navigating In The Single-Use Space: How To Find The Right Cell Culture Bioreactor By GE Healthcare Life Sciences
The bioreactor is the cornerstone on which cell culture for biopharmaceutical production is based. The bioreactor should provide an efficient means to expand the cell culture and to repeatedly deliver a product with the desired quality attributes. Choosing the right bioreactor is vital, but how do you know which bioreactor is the most suitable for your applications?
IBC Life Sciences 6th Annual BPI China is the foremost event on Bioprocessing and Biomanufacturing. Coming to China this August, BPI China offers 20 case studies, 17 new data presentations, panel discussions on biosimilar and analytical methods, and a keynote from China's SFDA. BPI China offers the most comprehensive coverage of China's evolving biologics market. View our agenda today for more information.
Sartorius Stedim Biotech introduced the first single-use bag for biopharmaceutical applications. Since then, demand for these bioprocessing bags has been rapidly increasing for use in critical applications. Their robustness, performance, and compliance are crucial for ensuring process safety and economy.
The Zeta Plus Encapsulated System consists of three product lines: a small system that is ideal for lab-scale production or scale-up studies, and two larger systems that are designed for production-scale biomanufacturing.
One thing unites all of us here at Envirotainer: our belief that the pharma products being shipped in our containers are of greater value to people than any price that can be put on them. And we believe that the active cold chain is the best way to protect this value.